Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hollis-Eden | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Hollis-Eden

James M. Frincke, Ph.D. has been named president and chief executive officer of Hollis-Eden Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

James M. Frincke, Ph.D. has been named president and chief executive officer of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was also elected to the company’s board of directors.

Dr. Frincke joined Hollis-Eden in 1997 as vice president, R&D, was promoted to executive vice president in 1999, and to chief scientific officer in 2001. He joined Hollis-Eden from Prolinx, Inc., where he served as vice president, Therapeutics R&D, from 1995 to 1997. During his 28 years in the biotechnology industry, Dr. Frincke has managed major development programs including drugs, biologicals, and cellular and gene therapy products aimed at the treatment of cancer, infectious diseases and organ transplantation.

Dr. Frincke has held vice president, R&D positions in top-tier biotechnology companies including Hybritech/Eli Lilly and SyStemix Inc. (acquired by Novartis). In various capacities, he has been responsible for all aspects of pharmaceutical development including early stage research programs, product evaluation, pharmacology, manufacturing, and the management of regulatory and clinical matters for lead product opportunities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters